SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-05 |
| Reported value | $254,232,337 |
| Positions | 5 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| BIOVENTUS INC | BVS | COM CL A | $122,921,299 | 13,021,324 |
| MIMEDX GROUP INC | MDXG | COM | $108,551,709 | 28,195,249 |
| EYEPOINT PHARMACEUTICALS INC | EYPT | COM NEW | $15,513,455 | 1,084,857 |
| TELA BIO INC | TELA | COM | $5,786,032 | 7,714,709 |
| MEDICINOVA INC | MNOV | COM NEW | $1,459,842 | 1,105,941 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.